拉斯信号传递和免疫细胞:瘤微环境中的一个险恶的交叉声
Yongting Liu1, Bin Xie1, Qiong Chen2,3,4
1Department of Geriatrics, Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
Journal of translational medicine
|September 5, 2023
概括
RAS突变在癌症中很常见,并影响瘤的免疫微环境. 本综述涵盖了针对RAS的疗法及其在癌症治疗中具有持久临床益处的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 鼠肉瘤病毒 (RAS) 基因是人类癌症中最常发生突变的瘤基因,约有19%的患者有这种突变.
- 拉斯突变显著影响瘤免疫微环境 (TIM),影响免疫细胞功能和瘤免疫逃避.
- 最近的研究强调了RAS信号与瘤背景下的免疫反应之间的复杂关系.
研究的目的:
- 审查针对RAS突变的直接和间接治疗策略.
- 阐明RAS信号调节免疫透和逃逸的机制.
- 讨论针对RAS的免疫疗法和组合方法的进展,以改善临床结果.
主要方法:
- 对研究RAS突变和瘤免疫微环境的文献综述.
- 对RAS信号通路及其免疫调节作用的现有证据的分析.
- 综合有关新兴RAS向疗法的数据,包括癌症疫苗和采用细胞疗法.
主要成果:
- 拉斯突变在塑造TIM中起着至关重要的作用,影响免疫细胞的招募,激活和分化.
- 拉斯信号传递有助于瘤细胞逃避免疫监测的能力.
- 目前正在开发针对RAS突变的各种直接和间接治疗策略.
结论:
- 了解RAS驱动的免疫调节对于开发有效的癌症治疗非常重要.
- 针对RAS的免疫疗法,特别是与个性化药物的结合策略,显示出对持久的临床反应的希望.
- 对RAS向治疗的进一步研究可能会导致瘤学的重大进展.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Autocrine Signaling
48.2K
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.2K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555


